« Return to News | Technology Solutions

Phase Forward Acquires Waban Software

Thursday, April 23, 2009 07:12 AM

Phase Forward, an eClinical company, acquired Waban Software, a Cambridge, Mass.-based clinical data analysis and reporting company with operations in Mumbai, India, for $14 million in cash.

Phase Forward’s Waltham, Mass., headquarters will become the local headquarters for Waban, which has 81 employees worldwide. Current Waban president Himanshu Oberoi, Ph.D., will become vice president, Waban Software Group, Phase Forward.

Phase Forward chairman and CEO Bob Weiler said the acquisition will help his company meet a “growing demand from life sciences companies to streamline the link between data management and biostatistics activities.”

Waban, now the Waban Software Group within Phase Forward, generated approximately $4 million in revenue and broke even during the full year 2008, according to a Phase Forward release. Phase Forward’s full-year 2008 GAAP revenues were $170.2 million, and as of December 31, 2008, the company had 718 employees, according to Phase Forward’s 2008 annual report.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.